PW
TGTX icon

Pandora Wealth’s TG Therapeutics TGTX Stock Holding History

Pandora Wealth’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.33M Sell
78,100
-200
-0.3% -$6.53K 1.41% 15
2025
Q3 		$2.83M Hold
78,300
– – 1.71% 12
2025
Q2 		$2.82M Sell
78,300
-5,400
-6% -$201K 1.73% 14
2025
Q1 		$3.3M Buy
+83,700
New +$2.82M 2.17% 11

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Pandora Wealth's TGTX Position: Q4 2025 in Review

Pandora Wealth reduced its TG Therapeutics (TGTX) stake by 0.26% in Q4 2025, selling an estimated $6.53K and leaving 78,100 shares worth $2.33M. The position accounts for 1.41% of the portfolio, ranked #15.

Pandora Wealth first reported a position in TGTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $3.3M in Q1 2025. 352 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Pandora Wealth held 78,100 shares of TG Therapeutics worth $2.33M as of Q4 2025.
  • Pandora Wealth sold 200 TG Therapeutics shares in Q4 2025, an estimated $6.53K.
  • TG Therapeutics made up 1.41% of Pandora Wealth's portfolio in Q4 2025, its #15 holding.
  • Pandora Wealth first reported a position in TG Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Pandora Wealth's TG Therapeutics position peaked at $3.3M in Q1 2025.
  • 352 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Pandora Wealth's 13F filing for Q4 2025, filed 4 Feb 2026.